Glenmark Pharmaceuticals Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Glenmark Pharmaceuticals Ltd with three other
companies in this sector in India:
Jubilant Life Sciences Limited
sales of 91.11 billion Indian Rupees [US$1.27 billion]
of which 58%
Torrent Pharmaceuticals Limited
(76.73 billion Indian Rupees [US$1.07 billion]
of which 100%
was Pharmaceuticals), and
Alkem Laboratories Ltd
(73.57 billion Indian Rupees [US$1.02 billion]
During the year ended March of 2019, sales at
Glenmark Pharmaceuticals Ltd were 98.65 billion Indian Rupees (US$1.37 billion).
increase of 8.4%
versus 2018, when the company's sales were 91.03 billion Indian Rupees.